US Approves $2.8 Billion Arms Deal for Israel Amid Gaza War

The United States has notified Congress of a new arms deal with Israel valued at approximately $2.8 billion, which includes tens of thousands of heavy bombs. According to a U.S. official, the sale comprises 40,000 bombs weighing 2,000 pounds each, including 20,000 MK-84 bombs and 20,000 BLU-117 bombs, along with 20,000 I-2000 bunker-buster warheads. These 2,000-pound bombs are among the heaviest conventional munitions produced by the U.S. and possess significant destructive power and bunker-penetrating capabilities, which have previously raised concerns about civilian casualties in densely populated areas.

This latest deal was informally presented to the congressional committees responsible for reviewing major arms sales. The Trump administration had previously utilized emergency authorities to expedite arms deals to Israel, shortening the standard review period. These sales continue a pattern of U.S. military support for Israel, extending from the previous administration.

A study by Brown University's Costs of War project indicates that the U.S. provided at least $21.7 billion in military aid to Israel between October 2023 and September 2025. This includes $17.9 billion in the first year of the conflict and $3.8 billion in the second year. The aid encompasses military financing, munitions, defensive systems, and costs associated with replenishing U.S. weapons stockpiles depleted by transfers to Israel.

The ongoing arms sales occur amidst Israel's continued military operations in the Gaza Strip. The deals have reignited debate regarding the types of weapons being used and the potential consequences of employing heavy munitions in areas with high population density.